Chimerix (CMRX) Short Interest Ratio & Short Volume → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free CMRX Stock Alerts $0.99 +0.02 (+1.83%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Chimerix Short Interest DataCurrent Short Volume1,360,000 sharesPrevious Short Volume1,320,000 sharesChange Vs. Previous Month+3.03%Dollar Volume Sold Short$1.28 millionShort Interest Ratio / Days to Cover3.2Last Record DateApril 30, 2024Outstanding Shares89,630,000 sharesFloat Size79,740,000 sharesShort Percent of Float1.71%Today's Trading Volume92,200 sharesAverage Trading Volume364,754 sharesToday's Volume Vs. Average25% Short Selling Chimerix ? Sign up to receive the latest short interest report for Chimerix and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCMRX Short Interest Over TimeCMRX Days to Cover Over TimeCMRX Percentage of Float Shorted Over Time Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… Chimerix Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,360,000 shares $1.28 million +3.0%1.7%3.2 $0.94 4/15/20241,320,000 shares $1.21 million +6.5%1.7%3.1 $0.91 3/31/20241,240,000 shares $1.31 million -1.6%1.6%3 $1.06 3/15/20241,260,000 shares $1.45 million -0.8%1.6%2.8 $1.15 2/29/20241,270,000 shares $1.46 million +2.4%1.6%3 $1.15 2/15/20241,240,000 shares $1.29 million -1.6%1.6%3.2 $1.04 Get the Latest News and Ratings for CMRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chimerix and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,260,000 shares $1.18 million +10.5%1.6%3.6 $0.94 1/15/20241,140,000 shares $1.09 million -7.3%1.4%3 $0.96 12/31/20231,230,000 shares $1.18 million -9.6%1.6%3 $0.96 12/15/20231,360,000 shares $1.32 million -14.5%1.7%3.2 $0.97 11/30/20231,590,000 shares $1.55 million +12.8%2.0%3.7 $0.97 11/15/20231,410,000 shares $1.35 million -14.6%1.8%3 $0.96 10/31/20231,650,000 shares $1.55 million -9.3%2.1%2.9 $0.94 10/15/20231,820,000 shares $1.79 million -6.7%2.3%2.8 $0.98 9/30/20231,950,000 shares $1.87 million +3.2%2.5%2.9 $0.96 9/15/20231,890,000 shares $1.97 million +6.2%2.4%2.7 $1.04 8/31/20231,780,000 shares $2.03 million -3.3%2.2%1.8 $1.14 8/15/20231,840,000 shares $1.78 million -0.5%2.3%1.7 $0.97 7/31/20231,850,000 shares $2.18 million +1.7%2.4%1.6 $1.18 7/15/20231,820,000 shares $2.17 million -3.7%2.4%1.6 $1.19 6/30/20231,890,000 shares $2.29 million -56.2%2.5%1.6 $1.21 6/15/20234,310,000 shares $6.25 million +15.6%5.8%3.7 $1.45 5/31/20233,730,000 shares $5.15 million +0.3%5.0%4 $1.38 5/15/20233,720,000 shares $4.24 million -9.3%5.0%3.9 $1.14 4/30/20234,100,000 shares $4.76 million +3.5%5.5%5.2 $1.16 4/15/20233,960,000 shares $4.75 million +4.5%5.3%5.2 $1.20 3/31/20233,790,000 shares $4.78 million +15.2%5.1%5.2 $1.26 3/15/20233,290,000 shares $4.47 million +17.5%4.4%4.4 $1.36 2/28/20232,800,000 shares $4.42 million -3.5%3.8%3.5 $1.58 2/15/20232,900,000 shares $4.87 million +6.6%3.9%3.5 $1.68 1/31/20232,720,000 shares $4.81 million +2.6%3.7%3 $1.77 1/15/20232,650,000 shares $5.46 million +4.3%3.6%2.7 $2.06 12/30/20222,540,000 shares $4.72 million -11.8%3.4%2.5 $1.86 12/15/20222,880,000 shares $5.70 million +0.7%3.9%2.7 $1.98 11/30/20222,860,000 shares $6.21 million -9.8%3.9%2.5 $2.17 11/15/20223,170,000 shares $6.94 million -8.9%4.3%1.8 $2.19 10/31/20223,480,000 shares $6.16 million -2.5%4.7%1.7 $1.77 10/15/20223,570,000 shares $6.39 million +4.4%4.8%1 $1.79 9/30/20223,420,000 shares $6.60 million +2.7%4.6%0.8 $1.93 9/15/20223,330,000 shares $7.49 million -17.8%4.5%0.7 $2.25Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. CMRX Short Interest - Frequently Asked Questions What is Chimerix's current short interest? Short interest is the volume of Chimerix shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 1,360,000 shares of CMRX short. 1.71% of Chimerix's shares are currently sold short. Learn More on Chimerix's current short interest. What is a good short interest ratio for Chimerix? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CMRX shares currently have a short interest ratio of 3.0. Learn More on Chimerix's short interest ratio. Which institutional investors are shorting Chimerix? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Chimerix: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Chimerix? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.71% of Chimerix's floating shares are currently sold short. Is Chimerix's short interest increasing or decreasing? Chimerix saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 1,360,000 shares, an increase of 3.0% from the previous total of 1,320,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Chimerix's float size? Chimerix currently has issued a total of 89,630,000 shares. Some of Chimerix's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Chimerix currently has a public float of 79,740,000 shares. How does Chimerix's short interest compare to its competitors? 1.71% of Chimerix's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Chimerix: Barinthus Biotherapeutics plc (0.05%), LifeVantage Co. (0.78%), Oncolytics Biotech Inc. (1.14%), Milestone Pharmaceuticals Inc. (0.81%), Annovis Bio, Inc. (14.41%), ProPhase Labs, Inc. (1.88%), YS Biopharma Co., Ltd. (0.32%), Spero Therapeutics, Inc. (0.87%), Eton Pharmaceuticals, Inc. (0.36%), IO Biotech, Inc. (0.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Chimerix stock? Short selling CMRX is an investing strategy that aims to generate trading profit from Chimerix as its price is falling. CMRX shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Chimerix? A short squeeze for Chimerix occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CMRX, which in turn drives the price of the stock up even further. How often is Chimerix's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CMRX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Barinthus Biotherapeutics Short Squeeze LifeVantage Short Squeeze Oncolytics Biotech Short Squeeze Milestone Pharmaceuticals Short Squeeze Annovis Bio Short Squeeze ProPhase Labs Short Squeeze YS Biopharma Short Squeeze Spero Therapeutics Short Squeeze Eton Pharmaceuticals Short Squeeze IO Biotech Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CMRX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersElon’s New Device is About to Shock the WorldInvestorPlaceDems have chosen Biden replacement?Paradigm PressBill Gates is all about this tiny $2 stockTimothy SykesDid You Get Your Free Bitcoin Yet?Crypto Swap Profits